In contrast to the tumour suppressive action of wtKLF6, the splice variants of KLF6, particularly SV1, have been found to have oncogenic properties and have been implicated in several types of cancer including lung, liver, ovarian and prostate [26]–[29]. The gene discussed is KLF6; the disease is cancer.